ArticleThe Journal of biological chemistry2020

Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency

Amanda R Luu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.